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Abstract 
The objective of this study was to analyze the effect of birth length on linear growth of 3-year-old toddlers. We 
used secondary data from a longitudinal study on nutritional status of pregnant women and their offspring in 
Bogor Regency. The variables used were hemoglobin, serum zinc and retinol, body height, height gained, and 
morbidity of toddlers. A multiple logistic regression was performed to analyze the effects. The results showed 
that linear growth failure at birth affected the further linear growth of toddlers. Furthermore, linear growth 
failure of toddlers was significantly affected by the growth failure at the first year of life, morbidity rate and 
micronutrient deficiencies with OR= 10.5, 3.0, and 2.5 respectively. This implies the need to prevent fetal linear 
growth failure by improving nutritional status of pregnant women and improving micronutrient status of 
children to prevent the high morbidity rate that may affect the linear growth of 3-year-old toddlers. 
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1. Introduction 
Linear growth failure (LGF) or height below the standard is a nutritional problem commonly found in 
developing countries. By using WHO growth reference standards, prevalence of stunting in under-five children 
reaches 38.2% in Africa, 13.5% in Latin America regions, and 27.6% in Asia. The prevalence in Thailand, 
Malaysia, the Philippines and Indonesia are 15.7%, 17.2%, 32.3% and 39.2%, respectively [1,2]. In Indonesia, it 
varies between provinces, ranging from 22.5% to 58.4%. It indicates that stunting remains a public health 
problem in all provinces in Indonesia, based on WHO threshold for non-public health problem (20%) [3].  
According to Uauy [4], children born stunted due to fetal malnutrition not only have low height-for-age, but also 
may provide short- and long-term effects. In short term, stunting may increase morbidity and mortality rates, 
mainly due to infectious diseases such as diarrhea, measles, respiratory tract infection and malaria; thus, 
resulting in growth failure of the children. Stunting also has long-term effects such as decreasing intelligence 
level at school age, lowering the productivity in productive period, and resulting in lower earnings than the ones 
who are not stunted. In addition, in adulthood, stunted children are at risk of becoming overweight and having 
other metabolic complications, and ultimately at a higher risk of having degenerative diseases such as 
cardiovascular disease. Economically, short- and long-term effects of stunting may decrease average income of 
a country by 3.4%. Although regional and global prevalence of stunting are quite high, the determinant factors 
of LGF have not heretofore been obtained with certainty. Several epidemiologic studies show that suboptimal 
breastfeeding, supplementary feeding practice, frequency of having infectious diseases and long-term 
micronutrient deficiency are risk factors for LGF. Social factors such as access to health care, education, and 
environmental condition also play an important role in the high incidence of LGF in under-five children [5,6]. 
Nutritional status of the newborns, observed either from birth weight or birth length, is an important factor in the 
growth of infants and children. A community-based cohort study on 1-year-old toddlers in rural Malawi proved 
that mother with height below 150 cm, birth weight, inappropriate complementary feeding and high morbidity 
rate were the causal factors of stunting at 1 year of age [7]. Results of a study conducted by Schmidt and his 
colleagues [8] in 2002 in Bogor, West Java, showed that birth weight and length were strong predictors of 
nutritional status and infant linear growth until the age of 15 months. It means that normal nutritional status and 
adequate intake of nutrients just before and during pregnancy affect nutritional status and growth during 
infancy. LGF or stunting begins in utero and continues during the first two years of life, known as the first 1,000 
days of life. This period is considered as a window of opportunity for intervention. Height growth pattern of 
under-five children in three regions (Asia, Africa, Latin America and the Caribbean) have similarities, in which 
there is a sharp decline in length-for-age Z-scores (LAZs) from the age of 3 months to 9 months. The decline 
continues until the age of 24 months although it is not as big as that period [9]. Based on the description above, 
this study aimed to analyze the differences in linear growth between children with growth failure and the normal 
ones, and to analyze the risk factors for LGF in toddlers aged 3 years.   
2. Materials and Method 
2.1. Design, location and time of study 
The data were obtained from a longitudinal study by Center for Applied Health Technology and Clinical 
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Epidemiology (CAHTCE) conducted in five districts in Bogor Regency from 2011 to 2012.[10] The study was 
conducted in three phases. Phase 1 was conducted in 2011 on 323 mothers with gestational age of 12-14 weeks, 
and continued to phase 2 conducted in 2012 on infants aged 0-12 months born to pregnant women in phase 
1.[11] Phase 3 was conducted in 2015, when the children in phase 2 reached the age of 3 years. 
2.2. Research subjects 
A total sample in phase 1 of the study was 323 pregnant women. The total sample became 262 infants in phase 2 
and 190 toddlers aged 3 years in phase 3. Of that amount, there were 150 children with complete data including 
the length/height at age 6 months, 1 year and 3 years; consisting of 39 infants with birth LAZs ≤ -1 SD (LGF) 
and 111 with LAZs more than -1 SD (normal).  
2.3. Data type and collection method 
The dependent variable in this study was the change in linear growth of normal toddlers and the toddlers with 
intrauterine growth restriction. The independent variables for the changes in linear growth of 3-year-old toddlers 
were LAZ-based nutritional status at birth, age 6 and 12 months; hemoglobin levels; serum zinc levels; serum 
retinol levels; and morbidity in the last one month. Linear growth data were obtained from the measurement of 
body length at birth, age 6 and 12 months. The body length was measured in recumbent position by using 
measurement tool for body length with a degree of precision of 0.1 cm. Body height of the 3-year-old toddlers 
was measured in standing position by using microtoice with a degree of precision of 0.1 cm. Morbidity rates 
were determined by interview using questionnaires. Blood biochemical parameters collected were hemoglobin 
(Hb), serum zinc, and serum retinol. Hb levels in the blood were analyzed by using the cyanmethemoglobin 
method, serum retinol levels were measured by high pressure liquid spectroscopy (HPLC) method, and serum 
zinc levels were analyzed by using atomic absorption spectrophotometry (AAS) method. 
2.4. Data processing and analysis 
Linear growth was determined based on height-for-age Z-score (HAZ). Toddlers were defined as having LGF if 
their HAZs were ≤ -1 SD, and normal if more than -1 SD. Morbidity data were categorized as “often” if the 
frequency of sickness was ≥ 4 times/month and “seldom” if less than 4 times/month. Micronutrient-based 
nutritional status included Hb, serum retinol and zinc concentration. Hb level in the blood was categorized as 
low if it was less than 11 g/dL and normal if ≥ 11 g/dL. Serum retinol was low if it was less than 20 µg/dL and 
normal if ≥ 20 µg/dL. Meanwhile, serum zinc was categorized as low if its level was less than 0.7 mg/L and 
normal if ≥ 0.7 mg/L [12].  
We performed univariate, bivariate, and multivariate analyses. Univariate analysis was used to analyze subjects’ 
characteristics; changes in linear growth at birth, age 1 year and 3 years; morbidity rate; and micronutrient 
status. Bivariate analysis was performed to analyze the changes in linear growth and the association between the 
risk factors and LGF by using chi-square test. Multivariate analysis (multiple logistic regression) was used to 
determine the risk factor that contributes the most in growth pattern of 3-year-old toddlers.  
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2.5. Ethical clearance  
This study was a secondary data analysis of a longitudinal study conducted by CAHTCE. Therefore, the ethical 
approval referred to the main study which was obtained from the Ethic Committee of National Institute of 
Health and Research Department (NIHRD) Number: LB.02.01/5.2/KE.233/2015. The toddlers’ parents signed 
the informed consent as the approval of being the research subjects. 
3. Results and Discussion 
3.1. Subjects’ characteristics 
There were no significant differences found in maternal age during pregnancy, frequency of pregnancy, 
maternal education and number of family members between normal infants and the ones with birth-length 
faltering (Table 1). 
Table 1: Maternal characteristics 
Characteristics LGF Normal p-value 
Maternal age during pregnancy 
< 20 years or > 35 years 
20-35 years 
 
12 (30.8) 
27 (69.2) 
 
27 (24.3) 
84 (75.7) 
 
0.564 
Frequency of pregnancy 
> 2 times  
< 2 times 
1.31 ±1.51 
8 (20.5) 
31 (79.5) 
1.45 ± 1.57 
21 (20.6) 
81 (79.4) 
 
1.000 
Maternal education 
Junior high school or lower 
Senior high school or higher 
 
35 (89.7) 
4 (10.3) 
 
89 (80.2) 
22 (9.8) 
 
0.266 
 
Number of family members 
> 5 people 
< 5 people 
4.56 ± 2.27 
11 (28.2) 
28 (71.8) 
4.52 ± 2.13 
31 (27.9) 
80 (72.1) 
 
1.000 
 
Table 2 showed that birth-length faltering (BLF) was more common among male infants (53.9%) than female 
infants (46.1%). Birth weight was directly proportional to birth length, which was seen from 29.1% of BLF 
infants (p=0.005) who had low birth weight (LBW). Birth length had a significant association with the body 
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length of 12-month-old infants (p=0.038).   
Table 2: Nutritional status of children aged 0-3 years 
Characteristics Growth failure Normal p-value 
Infant’s gender 
Male 
Female 
 
21 (53.9) 
18 (46.1) 
 
50 (45.0) 
61 (55.0) 
 
0.447 
  
Birth weight 
< 2500 gram 
> 2500 gram 
2835.1 ± 385.3 
7 (21.9) 
32 (82.1) 
3347.2 ± 548.6 
2 (1.8) 
109 (98.2) 
 
0.005 
 
Birth length 46.87 ± 1.19 50.04 ± 1.94  
Body length at age 6 months 
     LGF 
     Normal 
64.91 ± 2.53 
17 (43.6) 
22 (56.4) 
65.82 ± 2.46 
29 (26.1) 
82 (73.9) 
 
0.067 
 
Body length at age 12 months 
     LGF 
     Normal 
72.19 ± 2.05 
24 (61.5) 
15 (38.5) 
73.16 ± 2.58 
45 (40.5) 
66 (59.5) 
 
0.038 
Height at age 3 years 
     LGF 
     Normal 
91.42 ± 2.89 
33 (84.6) 
6 (15.4) 
93.06 ± 4.20 
79 (71.2) 
32 (28.8) 
 
0.148 
 
3.2. Linear growth patterns of children aged 0-3 years 
Figure 1 showed that mean birth LAZ of LGF infants and normal infants were -1.38±0.52 and 0.35±1.03, 
respectively. In the first three months, LAZ of LGF infants increased but declined in subsequent months. 
Meanwhile, it steadily declined in normal-length infants and a substantial decline occurred in the span of the 
third and sixth months. 
However, until the age of 3 years, infants with normal length still had a higher mean HAZ (-1.63) than the ones 
with LGF since birth (-1.98). 
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Figure 1: Mean LAZ or HAZ from birth until the age of 3 years 
The results of our study showed that mean LAZ or HAZ of the newborns (-0.1) continued to decline until the 
age of 3 years (-1.7). Linear growth patterns in this study were consistent with the results in previous studies 
which indicated that stunting had started in utero and continued until the age of 2 years [13,14]. It was evident 
from mean LAZ of the newborns in developing countries (-0.5 SD) which continued to decline after birth and 
reached its lowest point (around -2.0 SD) at the age of 18-24 months. Similar results were found in cohort 
studies in five countries, i.e. Brazil, Guatemala, India, the Philippines, and South Africa. Mean LAZ of the 
newborns ranged from -0.22 in the Philippines to -1.47 in Guatemala. At the age of 2 years, there was a decline 
in mean LAZ ranging from -0.61 in Brazil to -3.28 in Guatemala [15]. 
3.3. Birth-length faltering and linear growth failure in 3-year-old toddlers 
In the period of 0-12 months, there were 24 (61.5%) infants with LGF at birth who also had the same condition 
at the age of 12 months. On the other hand, in normal-birth-length infants group, there were 45 (40.5%) infants 
with LGF at the age of 12 months. Therefore, the overall relative risk (RR) was 1.518 (95% CI: 1.086-2.122; 
p=0.023). It indicated that infants with growth failure at birth had 1.5 times higher risk to remain as LGF 
toddlers at the age of 1 year (Figure 2). Infants with normal birth length had 1.7 times chances to have decreased 
nutritional status at age 3 years (RR=1.665; 95% CI: 1.526-2.080).  Figure 2 showed that of 39 infants with 
BLF, only 15.4% who had normal body height at age 3 years. On the contrary, 71.2% of 111 infants with 
normal birth length had LGF.  
The pattern of decline in HAZ resulted in increased proportion of LGF problem with age; i.e. from 26.0% at 
birth to 30.7% at age 6 months, 46% at age 12 months, and 74.7% at age 3 years. It indicated that LGF was 
difficult to overcome until the age of 3 years. Increased prevalence of stunting was also found in the study by 
Svefors and his colleagues in Bangladesh [16].  
Linear growth in three regions (Africa, Asia, Latin America and the Caribbean) had the same pattern in which 
LGF began during the first month of life, faster than weight faltering which occurred at 3 months of age [9].  
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Figure 2: Linear growth of children aged 0-3 years 
3.4. Risk factors for linear growth in children aged 0-3 years 
At the age of 0-3 years, children’s linear growth was significantly affected by length faltering that occurred from 
age 6 months to 1 year with OR values of 5.100 and 8.800. The high rate of morbidity in the last one month had 
an effect on linear growth of the 3-year-old toddlers. Toddlers who got sick more than four times in the last one 
month had 2.4 times higher risk of having LGF at age 3 years (OR=2.357; 95% CI: 1.098-5.059). 
Table 3: Relation of birth-length, morbidity, and micronutrient status with linear growth of children aged 0-3 
years 
Variables LGF n (%) Normal n (%) OR (95% CI) p-value 
Birth-length  
    LGF (LAZ ≤ -1 SD) 
    Normal (LAZ > -1 SD) 
Length at age 6 months  
    LGF (LAZ ≤ -1 SD) 
    Normal (LAZ > -1 SD) 
Length at age 1 year  
    LGF (LAZ ≤ -1 SD) 
    Normal (LAZ > -1 SD) 
 
33 (29.5) 
79 (70.5) 
 
42 (37.5) 
70 (62.5) 
 
64 (57.1) 
48 (42.9) 
 
6 (15.8) 
32 (84.2) 
 
4 (8.7) 
 34 (89.5) 
 
5 (7.2) 
33 (86.8) 
 
2.228  
(0.851-5.830) 
 
5.100** 
(1.690-15.389) 
 
8.800** 
(3.198-24.217) 
 
0.085 
 
 
0.001 
 
 
0.000 
Frequency of sickness (morbidity) in 
the last one month 
    Often  (> 4 times) 
    Seldom  (< 4 times) 
 
 
66 (58.9) 
46 (41.1) 
 
 
14 (37.8) 
23 (62.2) 
 
 
2.357* 
(1.098-5.059) 
 
 
0.026 
Hb at age 3 years     
    Low (< 11 g/dL) 
    Normal  (> 11 g/dL) 
Serum zinc at age 3 years     
Low (< 0.7 mg/L) 
    Normal (> 0.7 mg/L) 
Serum retinol at age 3 years     
    Low (< 20 µg/dL) 
    Normal (> 20 µg/dL) 
 
24 (21.8) 
86 (78.2) 
 
66 (65.3) 
35 (34.7) 
 
12 (11.3) 
94 (88.7) 
 
7 (18.4) 
31 (81.6) 
 
16 (44.4) 
20 (55.6) 
 
1 (2.6) 
37 (97.4) 
 
1,236  
(0.484-3.153) 
 
2.357 
(1.086-5.115) 
 
4.723 
(0.593-37.626) 
 
0.654 
 
 
0.029 
 
 
0.074 
 
*) p value ≤ 0.05; **) p-value ≤ 0.01         
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Table 4: Risk factors for linear growth failure in children aged 1-3 years 
Risk factors OR (95% CI) p-value 
Linear growth failure at age 1 year (HAZ <-1 SD) 
Often get sick in the last one month (> 4 times) 
Zinc deficiency (serum zinc level < 0.7 mg/L)  
Vitamin A deficiency (retinol serum < 20 µg/dL) 
10.511 (3.527-31.325)** 
2.522 (1.033-6.159)* 
3.031 (1.222-7.515)* 
7.455 (0.802-69.254) 
0.000 
0.042 
0.017 
0.077 
*) p-value ≤ 0.05; **) p-value ≤ 0.01 
 
Data analysis on risk factors for LGF of children aged 0-3 years (Table 4) showed that linear growth at age 1 
year was a risk factor for LGF in 3-year-old toddlers with OR value of 10.511 (95% CI: 3.527-31.325; 
p=0.000). Other factors that might increase the risk of LGF in 3-year-old toddlers were zinc and vitamin A 
deficiencies, as well as how often the toddlers got sick in the last one month with OR values of 2.522, 7.455 and 
3.031, respectively. From the above equations, we got R2 value of 0.349 (p=0.000). It indicated that 34.9% of 
LGF that occurred among the 3-year-old toddlers were determined by the linear growth at age 1 year, the high 
levels of zinc and vitamin A, as well as how often they got sick in the last one month. Growth is a continuous 
process occurring in four phases of life; i.e. fetus, infant, child and puberty. Each phase is managed by different 
regulatory mechanisms and affected by endogenous factors (biological, genetic and determinant of ethnic) and 
exogenous factors (nutrition, culture, environment and social conditions). These four phases of growth are 
inextricably linked to one another. If growth failure occurs in one phase, it will affect the next growth phase if it 
is not balanced with catch-up growth [17]. The theory above is in line with this study, in which the linear growth 
of newborns until they are at age 1 year affects the length faltering which occurred in 3-year-old toddlers. 
Infants with LGF at age 6 months were 22.3 times at higher risk of having LGF at age 1 year. Meanwhile, the 
linear growth of 3-year-old toddlers was significantly affected by length faltering that occurred at age 1 year 
with an OR value of 8.800. High morbidity of infectious diseases might decrease the nutritional status of 3-year-
old toddlers. It was associated with micronutrient deficiencies, especially low Hb, serum retinol and serum zinc 
levels. Previous study proved that serum retinol levels in children with upper respiratory tract infection were 
lower than the healthy ones [18]. Similar results were obtained from another study in which iron, vitamin A and 
serum zinc were significantly lower in stunted children than the normal ones [19]. It indicates that vitamin A, 
zinc, and iron play an important role in linear growth. Zinc and vitamin A play a role in the immune system; 
thus, contributes to morbidity and growth failure. Zinc also plays a role in some of growth process through 
formation and secretion of growth hormones, activation of insulin-like growth factors (IGFs) and bone 
formation [19,20].  Limitations of this study were (1) the incomplete data, and lost to follow-up samples that 
may affect significance and power of data analysis. From 262 samples at the baseline only 150 children have 
complete data and can be analyzed; (2) no data collection of environmental factors such as home sanitation, use 
of clean water and smoking habits that can cause a high morbidity; (3) no analysis of food consumption data of 
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children due to the consumption data on the previous study were collected by 24 hours food recall method 
carried out once every month, so it does not reflect the daily intake.  
4. Conclusion and Recommendation 
This study indicated that length faltering at birth, age 6 months, an age 1 year had a significant effect on linear 
growth of 3-year-old toddlers. It is difficult for children with BLF to have a normal body length. On the 
contrary, children with normal birth length have a great chance to have LGF at age 3 years. LGF at age 0-1 
years, morbidity, and micronutrient deficiencies are three factors which affect the linear growth of 3-year-old 
toddlers. Fetal LGF should be prevented by improving the nutritional status of pregnant women and improving 
micronutrient status of the toddlers to prevent the high morbidity rates and LGF in 3-year-old toddlers.  
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